This programme has been developed independently and in partnership by both Issues & Answers in Primary Care (I&A) and the Primary Care Cardiovascular Society (PCCS) who jointly retain editorial control.
About this programme
Obesity and liver disease severely elevate the likelihood of chronic disease progression and primary care will play a crucial role in the early detection, risk stratification, and long-term management of the conditions, with a major opportunity to prevent progression and improve outcomes.
This programme is aimed at Primary Care HCPs – GPs, pharmacists and nurses who see these patients on a daily basis where there is an unmet need in terms of translating current evidence and the latest guidance into front line clinical practice whilst working with a multi-disciplinary team.
Over the next 6 months the programme, through webinars, podcasts and online modules, will tackle the important aspects of care of these patients and aims to increase awareness and expand knowledge in order to allow healthcare professionals to recognise the importance of identifying the risks of chronic disease progression, gain the confidence to begin early interventions and to offer optimal management of said conditions.
You must be an Issues & Answers member* to register for this programme, Login here.
*If you are not already a member click here to register for FREE.
Programme agenda
Part 1 – Webinar – Wednesday 25th November, 7pm
Obesity & Liver Disease: Examining the Risks of Chronic Disease Progression
- Webinar discussion with the experts talking about obesity and liver disease, what are the potential complications and associated comorbidities, who is at risk and what testing is available, including case study examples and audience Q&A.
Speakers:
Beverley Bostock RN MSc MA Queen’s Nurse
President, Primary Care Cardiovascular Society
Specialist Nurse – Long-Term Conditions, Mann Cottage Surgery
Prof Derek Connolly BSc[Hons] MBChB[Edin] PhD[Cantab] DSc[Hon] FRCP FRCPE FESC
Consultant Cardiologist – The Midland Metropolitan University Hospital
Vice Chancellor’s Professor of Fellow in healthcare research at Aston University Birmingham
TBC
Part 2 – Online modules – A series of monthly modules
Module 1 – December
Liver Specific Risks & Disease progression
Individuals with obesity and chronic liver disease face a higher risk of decompensated liver failure.
- Podcast – Expert summary
- Explainer paper – The epidemiology of obesity and liver disease progression
- Written case study with CPD questions – Looking at a person living with obesity and liver disease who goes on to develop fibrosis and cirrhosis and eventually liver failure
Beverley Bostock RN MSc MA Queen’s Nurse
President, Primary Care Cardiovascular Society
Specialist Nurse – Long-Term Conditions, Mann Cottage Surgery
Prof Derek Connolly BSc[Hons] MBChB[Edin] PhD[Cantab] DSc[Hon] FRCP FRCPE FESC
Consultant Cardiologist – The Midland Metropolitan University Hospital
Vice Chancellor’s Professor of Fellow in healthcare research at Aston University Birmingham
Module 2 – January
Cardiovascular Specific Risks & Disease Progression
The leading cause of mortality in patients with fatty liver disease. The combination of obesity and liver disease significantly accelerates atherosclerosis, increasing the risk of heart attacks and strokes.
- Podcast – Expert summary
- Explainer paper – The epidemiology of obesity, liver disease and the risk of CVD
- Written case study with CPD questions – Looking at a person living with obesity and liver disease who goes on to develop cardiovascular disease.
Helen Williams
National Clinical Director for CVD Prevention,
NHSE and Consultant Pharmacist for CVD, SE London ICB and UCL Partners
Module 3 – February
Metabolic Syndrome Specific Risks & Disease Progression
Both conditions are core drivers of Type 2 diabetes, high blood pressure (hypertension), and unhealthy blood lipids (dyslipidaemia).
- Podcast – Expert summary
- Explainer paper – The epidemiology of obesity, liver disease and the risk of metabolic syndrome
- Written case study with CPD questions – Looking at a person living with obesity and liver disease who goes on to develop metabolic syndrome.
Alison Warren
Consultant Pharmacist for Cardiology, Sussex Clinical Commissioning Groups
and University Hospitals Sussex
Module 4 – March
Chronic Kidney Disease (CKD) Specific Risks & Disease Progression
Advanced liver disease and obesity are strongly associated with a higher likelihood of developing or worsening CKD.
- Podcast – Expert summary
- Explainer paper – The epidemiology of obesity, liver disease and the risk of CKD
- Written case study with CPD questions – Looking at a person living with obesity and liver disease who goes on to develop CKD
Prof Raj Thakkar
GP partner since 2004, Primary Care Cardiology Lead for Oxford Health Innovation
Honorary Visiting Professor at Cardiff University Medical School
Module 5 – April
Sleep Apnoea Specific Risks & Disease Progression
Obstructive sleep apnoea is highly prevalent in populations with obesity and MASH/NAFLD, worsening systemic inflammation.
- Podcast – Expert summary
- Explainer paper – The epidemiology of obesity, liver disease and the risk of sleep apnoea
- Written case study with CPD questions – Looking at a person living with obesity and liver disease who goes on to develop apnoea
Iain Wheatley
Nurse Consultant Sleep and Ventilation
Vice Chair Association of Respiratory Nurses / Co-Chair OSA alliance
Module 6 – May
Oncological Specific Risks & Disease Progressioncific Risks & Disease Progression
Obesity and advanced liver disease independently and collaboratively increase the risk of several cancers, including colorectal, pancreatic, and oesophageal cancers.
- Podcast – Expert summary
- Explainer paper – The epidemiology of obesity, liver disease and the risk of cancers
- Written case study with CPD questions – Looking at a person living with obesity and liver disease who goes on to develop colorectal cancer
Dr Siva Tharshini Ramalingam
GP Partner ICOS board-certified cardio-oncologist , Oxted Health Centre in Surrey,
The Royal Brompton Hospital, London
Part 3 – Webinar with Back-to-Basics Infographic – Tuesday 22nd June, 7pm
Obesity & Liver Disease: Limiting the risk and preventing complications
- Webinar discussion with the experts talking about obesity, liver disease and the risks. Reminders of what interventions can be made in practice to identify persons at risk, limit the risks and prevent complications, and how to manage these conditions effectively with a multidisciplinary team. Including successful case study examples and audience Q&A
- Downloadable Back to Basics infographic – Obesity and Liver Disease: The Risks of Chronic Disease Progression
Speakers:
Beverley Bostock RN MSc MA Queen’s Nurse
President, Primary Care Cardiovascular Society
Specialist Nurse – Long-Term Conditions, Mann Cottage Surgery
Prof Derek Connolly BSc[Hons] MBChB[Edin] PhD[Cantab] DSc[Hon] FRCP FRCPE FESC
Consultant Cardiologist – The Midland Metropolitan University Hospital
Vice Chancellor’s Professor of Fellow in healthcare research at Aston University Birmingham
Dr. Sarah Davies
GP in Cardiff with a special interest in diabetes
All Wales lead for diabetes in primary care
Clinical Director for Diabetes in primary care for Cardiff and Vale UHB
Diabetes UK Clinical Champion
Presenter for NB Medical Hot Topics, leading their diabetes course
You must be an Issues & Answers member* to register for this programme, Login here.
*If you are not already a member click here to register for FREE.
This educational programme has been supported by:
Boehringer Ingelheim (BI) has provided funding for this independent Programme. BI has had no editorial input into or influence over the agenda, content of this Programme or choice of speakers and authors.
The content, opinions and statements made in this Programme have been developed independently by the presenters and do not necessarily reflect the views of the supporter(s), editors or editorial board.
